drugset / Trial / NCT00397553
Insulin Glulisine, Diabetes Mellitus Type 1
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To provide local data on efficacy and safety of insulin glulisine in patients with Type 1 Diabetes Mellitus receiving insulin glargine as basic insulin therapy
Timeline
- Start
- 2005-01
- Primary completion
- 2007-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin glulisine | Protein / enzyme biologic | — | Subcutaneous |